Genital Herpes Treatment Market

Future Market Insights suggests that within the genital herpes treatment market landscape, the convergence of mRNA vaccine platforms and next-generation helicase-primase inhibitors is creating a distinct inflection in therapeutic options beyond legacy nucleoside analogues. Analysts identify clinical-stage pipeline assets as the central pivot point for the industry, effectively redirecting licensing capital toward novel antiviral mechanisms.